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Introduction
Insulin is essential in type 1 diabetes, including the
emergency treatment of ketoacidosis. It may also be 
needed in type 2 diabetes for intercurrent events like 
surgery, infections, serious illness, trauma, pregnancy and
for emergency treatment of hiperkalemia (1). While insulin
has an essential role in the management of patients with 
insulin deficiency, its clinical use may lead to adverse 
effects such as hypoglycaemia and weight gain. The reason
of weight gain associated with insulin treatment is poorly
understood and has been attributed to increased vascular
permeability and shifted renal sodium handling in addition to
the anabolic effect of insulin. Rarely, crucial fluid retention
can occur with insulin therapy. Peripheral or generalised 
oedema is an extraordinary complication of insulin therapy in
the absence of heart, liver or renal involvement. It has been
reported in newly diagnosed type 1 diabetes, in poorly 
controlled type 2 diabetes following the initiation of insulin
therapy, and in underweight patients on large doses of 
insulin. The oedematous state develops briefly after the 
initiation of intensive insulin therapy (2-4). The pathophysiology
remains vague, although the condition was first described
as early as 1928 (3). Reported cases of insulin-induced 
oedema in childhood and adolescence are scarce (1,5). The
first pediatric report dates back to 1979 (6), and ten more 
cases have been reported since then (6-9). Herein we 
describe insulin oedema in two adolescent girls with newly
diagnosed diabetes.
ABSTRACT
Despite the essential role of insulin in the management of patients with 
insulin deficiency, insulin use can lead to adverse effects such as 
hypoglycaemia and weight gain. Rarely, crucial fluid retention can occur
with insulin therapy, resulting in an oedematous condition. Peripheral or 
generalised oedema is an extremely rare complication of insulin therapy
in the absence of heart, liver or renal involvement. It has been reported
in newly diagnosed type 1 diabetes, in poorly controlled type 2 diabetes
following the initiation of insulin therapy, and in underweight patients
on large doses of insulin. The oedema occurs shortly after the initiation
of intensive insulin therapy. We describe two adolescent girls with
newly diagnosed type 1 diabetes, who presented with oedema of the 
lower extremities approximately one week after the initiation of insulin
treatment; other causes of oedema were excluded. Spontaneous 
recovery was observed in both patients. 
K Ke ey y   w wo or rd ds s: : Type 1 diabetes, insulin oedema, adolescence
R Re ec ce ei iv ve ed d: : 30.9.2009 A Ac cc ce ep pt te ed d: : 05.11.2009
This is an open-access article distributed under the terms of the Creative Commons Attiribution License, which 
permits unrestricted use, distribution and reprodiction in any medium, provided the original work is properly cited.Case 1
A 14-year-old girl was admitted with a 1-month history
of polyuria and polydipsia. A recent weight loss of 5 kg was 
also mentioned. No family history of diabetes was 
reported. Physical examination at the time of admission 
revealed a temperature of 36.7
0C, a pulse of 66 beats per
minute, a respiratory rate of 24 per minute, and a blood
pressure of 110/70 mm/Hg. The patient’s height was 
161 cm (-0.01 SDS) and her weight was 40 kg (-2.85 SDS).
Calculated body mass index was 15.6 kg/m
2 (-2,7 SDS). 
Careful history excluded anorexia nervosa as a contributing
condition to her weight loss. She was at pubertal Tanner
stage 5. Laboratory investigations revealed a blood glucose
level of 363 mg/dL, ketonuria with acidosis, an arterial 
blood pH of 7.2 and an elevated glycosylated haemoglobin
A1c concentration of 12.1%. The patient was initially 
treated with an intravenous infusion of insulin and 2/3 
isotonic saline in 5% dextrose. Mild bilateral pitting ankle
oedema and discoloration of the skin developed over the
ankles. The oedema deteriorated on the fourth day, after
the initiation of regular insulin administered subcutaneously,
at a dose of 1.2 units/kg/day (Figure 1). No evidence of 
heart, liver or kidney dysfunction was noted. Serum 
albumin levels decreased from 3.5 to 3.2 g/dL, without 
proteinuria. Chest X-ray and abdominal ultrasound findings
were normal. Doppler ultrasound findings of the lower leg
arteries and veins were normal. Ten days later the oedema
had completely resolved without any specific treatment.
Case 2
An 11-year-old girl was admitted with an 8-month 
history of polyuria, polydipsia and a recent weight loss of 7 kg.
No family history of diabetes was reported. Physical exami-
nation at the time of admission revealed a temperature of
37
0C, a pulse rate of 96 beats per minute, a respiratory rate
of 28 per minute, and a blood pressure of 
100/65 mm/Hg. Her height was 147 cm (-0.31 SDS) and her
weight 30 kg (-1.75 SDS). Calculated body mass index was
13.8 (-1.9 SDS) kg/m
2. Pubertal stage was evaluated as Tan-
ner stage 3. Physical examination was normal except for cli-
nical signs of mild dehydration. Laboratory investigations re-
vealed a blood glucose level of 453 mg/dL, ketonuria with
acidosis, an arterial blood pH of 7.1 and an elevated
glycosylated haemoglobin A1c concentration of 13.9%. The
patient was treated with 2/3 isotonic saline in %5 dexstrose
and intravenous insulin infusion. On the fifth day of regular
insulin administration, a non-tender, pitting oedema 
without skin discoloration developed over the ankles 
(Figure 2). No evidence of heart, liver or renal dysfunction
was noted. Serum albumin levels remained stable. Chest 
X-ray and abdominal ultrasound findings were normal.
Doppler ultrasound findings of the lower leg arteries and 
veins were normal. Seven days later the oedema disappeared
completely without any treatment. 
Further investigations revealed positive anti-GAD 
(glutamic acid decarboxylase) and anti-islet cell antibodies in
both patients.
Discussion
Insulin oedema is presumably an underreported physical
finding. The severity of the peripheral oedema is variable,
most cases being mild. Oedema has been accepted as an
uncommon complication occurring after initiating or 
intensifying the insulin treatment (3). Leifer (2), in 1928, 
proposed that rapid retention of tissue fluid secondary to
glycogen deposition was responsible for the pathophysiology
of insulin oedema. In subsequent years, the direct 
antinatriuretic effect of insulin on the kidney was recognised
and insulin oedema was attributed to alterations in renal
electrolyte transport (10). Insulin-induced oedema was 
found to occur equally in adult men and women, but a 
clear female predominance was noted in younger ages
(3,6). Both our patients were also females. In addition, the
reported pediatric cases were all recently diagnosed 
patients with type 1 diabetes, similar to our patients. 
Intensive fluid resuscitation in an insulin-deficient catabolic
state may lead to extravasation of fluid to the subcutaneous
tissue, resulting in peripheral oedema. This may be 
exacerbated by the increased capillary permeability associated
with chronic hyperglycaemia (11). Renal tubular sodium 
reabsorption is enhanced by insulin therapy via stimulating
the Na+/K+-ATPase as well as the expression of Na+/H+
exchanger 3 in the proximal tubule (12,13). Transient 
inappropriate hyperaldosteronism has also been suggested
to contribute to the fluid retention (12). In our cases, normal
plasma aldosterone/renin ratio was accompanied by significant
natriuresis, leading to recovery of the abnormal sodium
handling in the renal tubules. Interestingly, many of the 
described patients with insulin-induced oedema were 
substantially underweight, with the most dramatic 
presentation occurring in the underweight patients (14), a
finding similar to our two cases. Our patients were thin 
adolescents, who had considerable weight loss before 
admission. In several patients it was reported that loss of 
albumin from the circulation due to increased transcapillary
leakage probably contributed to the formation of oedema
and the decreased serum albumin, but was not severe 
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lar findings were true for our patients. Cases with normal
serum albumin have also been reported. Clinically, insulin
oedema may present with a spectrum of severity from mild
pedal oedema to frank anasarca. Pleural effusions have 
uncommonly been reported, although some of these 
patients were elderly and may have had pre-existing 
cardiac disease. Rarely, the oedema extended from 
peripheral tissues to serosal cavities with ascites and 
cardiac failure (14,16,17).
In patients with insulin oedema, fluid and salt restriction
should be implemented and this may be all that is necessary.
Diuretic therapy may be indicated in more severe 
decompensated cases. Administration of an aldosterone 
antagonist such as spironolactone may be considered from a
pathophysiological point of view in the presence of 
inappropriate hyperaldosteronism; however, the treatment
with other diuretics appears to be also effective (12). In most
instances no therapy is needed and spontaneous recovery is
noted, as was the case in our patients.
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Figure 1. Lower extremity oedema 4 days after the initiation of insu-
lin therapy in Case 1
Figure 2. Lower extremity oedema 5 days after the initiation of insu-
lin therapy in Case 2
Abstract]